KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Return on Assets (2016 - 2025)

Historic Return on Assets for Supernus Pharmaceuticals (SUPN) over the last 14 years, with Q3 2025 value amounting to 0.01%.

  • Supernus Pharmaceuticals' Return on Assets fell 600.0% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year decrease of 600.0%. This contributed to the annual value of 0.06% for FY2024, which is 500.0% up from last year.
  • Latest data reveals that Supernus Pharmaceuticals reported Return on Assets of 0.01% as of Q3 2025, which was down 600.0% from 0.05% recorded in Q2 2025.
  • Over the past 5 years, Supernus Pharmaceuticals' Return on Assets peaked at 0.07% during Q1 2021, and registered a low of 0.01% during Q3 2025.
  • Its 5-year average for Return on Assets is 0.03%, with a median of 0.03% in 2022.
  • Data for Supernus Pharmaceuticals' Return on Assets shows a peak YoY increase of 600bps (in 2025) and a maximum YoY decrease of -600bps (in 2025) over the last 5 years.
  • Quarter analysis of 5 years shows Supernus Pharmaceuticals' Return on Assets stood at 0.03% in 2021, then increased by 9bps to 0.04% in 2022, then crashed by -97bps to 0.0% in 2023, then skyrocketed by 5337bps to 0.05% in 2024, then crashed by -125bps to 0.01% in 2025.
  • Its Return on Assets was 0.01% in Q3 2025, compared to 0.05% in Q2 2025 and 0.05% in Q1 2025.